Análisis de la aceptación del pasaporte de inmunidad ante la covid-19 con una escala ética múltiple.
- Jorge de Andrés Sánchez 1
- Mario Arias Oliva 2
- Jorge Pelegrín-Borondo 3
- Ala’ Ali Mohammad Almahameed 1
- Orlando Lima 4
-
1
Universitat Rovira i Virgili
info
-
2
Universidad Complutense de Madrid
info
-
3
Universidad de La Rioja
info
-
4
Instituto Politécnico do Porto
info
- Teresa Torres-Coronas (ed. lit.)
- Josep Moreno-Gené (ed. lit.)
- Angel Belzunegui-Eraso (ed. lit.)
Editorial: Universitat Rovira i Virgili
Año de publicación: 2021
Páginas: 417-432
Tipo: Capítulo de Libro
beta Ver similares en nube de resultadosResumen
The existence of an immunity passport (IP) can allow, while the world population achieves group immunity, to relax the mobility and assembly restrictions for those people who prove to be immunized. Methods: A cross-sectional survey of 400 residents in Spain, conducted in the second half of April 2021. It was considered separately that the IP can be used to travel regulation or to restrict access to public places. This work analyses the perception of this instrument with a multiple ethical scale and the factors that affect that perception. Results: We observed a statistically significant positive perception in the items related to egoism, utilitarianism (in both uses of IP) and social norm (if the use of the IP was for traveling). We also found a better assessment of the use of IP when the objective is travel than if the objective is to limit access to public places and activities, which is statistically significant in the judgements on social norm and usefulness. We have observed that the fact of being vaccinated has a significant impact on the positive assessment of PI. Gender, age (having overcome the disease) have a positive (negative) and significant impact only on limited dimensions and not for both uses of IP. The number of tests a person underwent and educational degree have no significant relationship with the attitude towards IP. Conclusions: The results may be useful to guide the policy that health authorities should carry out for the use of IP.